Molecular interaction between factor VII and tissue factor

International Journal of Hematology

Volumn 67, Issue 3, 1998, Pages 229-241

  Higashi, Shouichi ^a   Iwanaga, Sadaaki ^b  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Conformational transition; Factor VIIa; Molecular interaction; Tissue factor

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 7; THROMBOPLASTIN;

ARTICLE; BINDING AFFINITY; BLOOD CLOTTING; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; DRUG DESIGN; HUMAN; MODEL; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL;

EID: 0032053072     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0925-5710(98)00018-8     Document Type: Article

References (55)

1. Silverberg S.A., Nemerson Y., Zur M. Kinetics of the activation of bovine coagulation factor X by components of the extrinsic pathway. Kinetic behavior of two-chain factor VII in the presence and absence of tissue factor. J Biol Chem. 252:1977;8481-8488.
2. Nemerson Y. Tissue factor and hemostasis. Blood. 71:1988;1-8.
3. Davie E.W., Fujikawa K., Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry. 30:1991;10363-10370.
4. Edgington T.S., Mackman N., Brand K., Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost. 66:1991;67-79.
5. Shigematsu Y., Miyata T., Higashi S., Miki T., Sadler J.E., Iwanaga S. Expression of human soluble tissue factor in yeast and enzymatic properties of its complex with factor VIIa. J Biol Chem. 267:1992;21329-21337.
6. Lawson J.H., Butenas S., Ribarik N., Mann K.G. Complex-dependent inhibition of factor VIIa by antithrombin III and heparin. J Biol Chem. 268:1993;767-770.
7. Girard T.J., Warren L.A., Novotny W.F.et al. Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature. 338:1989;518-520.
8. Morrissey J.H., Macik B.G., Neuenschwander P.F., Comp P.C. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood. 81:1993;734-744.
9. Pedersen A.H., Nordfand O., Norris F.et al. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions. J Biol Chem. 265:1990;16786-16793.
10. Ruf W., Kalnik M.W., Lund-Hansen T., Edgington T.S. Characterization of factor VII association with tissue factor in solution. High and low affinity calcium binding sites in factor VII contribute to functionally distinct interactions. J Biol Chem. 266:1991;15719-15725.
11. Lawson J.H., Butenas S., Mann K.G. The evaluation of complex-dependent alterations in human factor VIIa. J Biol Chem. 267:1992;4834-4843.
12. Higashi S., Nishimura H., Fujii S., Takada K., Iwanaga S. Tissue factor potentiates the factor VIIa-catalyzed hydrolysis of an ester substrate. J Biol Chem. 267:1992;17990-17996.
13. Neuenschwander P.F., Branam D.E., Morrissey J.H. Importance of substrate composition, pH and other variables on tissue factor enhancement of factor VIIa activity. Thromb Haemost. 70:1993;970-977.
14. Jesty J., Lorenz A., Rodriguez J., Wun T.C. Initiation of the tissue factor pathway of coagulation in the presence of heparin: control by antithrombin III and tissue factor pathway inhibitor. Blood. 87:1996;2301-2307.
15. Banner D.W., D'Arcy A., Chene C.et al. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature. 380:1996;41-46.
16. Inoue K., Shimada H., Ueba J.et al. High-affinity calcium-binding site in the γ-carboxyglutamic acid domain of bovine factor VII. Biochemistry. 35:1996;13826-13832.
17. Morita T., Jackson C.M. Preparation and properties of derivatives of bovine factor X and factor Xa from which the γ-carboxyglutamic acid containing domain has been removed. J Biol Chem. 261:1986;4015-4023.
18. Higashi S., Nishimura H., Aita K., Iwanaga S. Identification of regions of bovine factor VII essential for binding to tissue factor. J Biol Chem. 269:1994;18891-18898.
19. Higashi S., Matsumoto N., Iwanaga S. Molecular mechanism of tissue factor-mediated acceleration of factor VIIa activity. J Biol Chem. 271:1996;26569-26574.
20. 2-Glc) O-glycosidically linked to a serine residue in the first epidermal growth factor-like domain of human factors VII and IX and protein Z and bovine protein Z. J Biol Chem. 264:1989;20320-20325.
21. 2Glc-O-Ser-53 found in the first epidermal growth factor-like domain of bovine blood clotting factor IX. J Biol Chem. 265:1990;1858-1861.
22. Bjoern S., Foster D.C., Thim L.et al. Human plasma and recombinant factor VII. Characterization of O-glycosylations at serine residues 52 and 60 and effects of site-directed mutagenesis of serine 52 to alanine. J Biol Chem. 266:1991;11051-11057.
23. Takeya H., Kawabata S., Nakagawa K., Yamamichi Y., Miyata T., Iwanaga S. Bovine factor VII. Its purification and complete amino acid sequence. J Biol Chem. 263:1988;14868-14877.
24. 2+ binding to the first epidermal growth factor module of coagulation factor VIIa is important for cofactor interaction and proteolytic function. J Biol Chem. 272:1997;17467-17472.
25. 2+ binding to the first epidermal growth factor-like domain of factor VIIa increases amidolytic activity and tissue factor affinity. J Biol Chem. 272:1997;19919-19924.
26. 2+-binding site in the serine protease domain of human factor VIIa and its role in tissue factor binding and development of catalytic activity. J Biol Chem. 270:1995;15523-15530.
27. Bazan J.F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA. 87:1990;6934-6938.
28. Harlos K., Martin D.M., O'Brien D.P.et al. Crystal structure of the extracellular region of human tissue factor. Nature. 370:1994;662-666.
29. Rehemtulla A., Ruf W., Edgington T.S. The integrity of the cysteine 186-cysteine 209 bond of the second disulfide loop of tissue factor is required for binding of factor VII. J Biol Chem. 266:1991;10294-10299.
30. Takayenoki Y., Muta T., Miyata T., Iwanaga S. cDNA and amino acid sequence of bovine tissue factor. Biochem Biophys Res Commun. 181:1991;1145-1150.
31. Bach R., Konigsberg W.H., Nemerson Y. Human tissue factor contains thioester-linked palmitate and stearate on the cytoplasmic half-cystine. Biochemistry. 27:1988;4227-4231.
32. Zioncheck T.F., Roy S., Vehar G.A. The cytoplasmic domain of tissue factor is phosphorylated by a protein kinase C-dependent mechanism. J Biol Chem. 267:1992;3561-3564.
33. Mody R.S., Carson S.D. Tissue factor cytoplasmic domain peptide is multiply phosphorylated in vitro. Biochemistry. 36:1997;7869-7875.
34. O'Brien D.P., Kemball-Cook G., Hutchinson A.M.et al. Surface plasmon resonance studies of the interaction between factor VII and tissue factor. Demonstration of defective tissue factor binding in a variant FVII molecule (FVII-R79Q). Biochemistry. 33:1994;14162-14169.
35. Ruf W., Schullek J.R., Stone M.J., Edgington T.S. Mutational mapping of functional residues in tissue factor: identification of factor VII recognition determinants in both structural modules of the predicted cytokine receptor homology domain. Biochemistry. 33:1994;1565-1572.
36. O'Brien D.P., Gale K.M., Anderson J.S.et al. Purification and characterization of factor VII 304-Gln: a variant molecule with reduced activity isolated from a clinically unaffected male. Blood. 78:1991;132-140.
37. Matsushita T., Kojima T., Emi N., Takahashi I., Saito H. Impaired human tissue factor-mediated activity in blood clotting factor VII Nagoya (Arg304→Trp). Evidence that a region in the catalytic domain of factor VII is important for the association with tissue factor. J Biol Chem. 269:1994;7355-7363.
38. Bharadwaj D., Iino M., Kontoyianni M., Smith K.J., Foster D.C., Kisiel W. Factor VII Central. A novel mutation in the catalytic domain that reduces tissue factor binding, impairs activation by factor Xa, and abolishes amidolytic and coagulant activity. J Biol Chem. 271:1996;30685-30691.
39. Bernardi F., Liney D.L., Patracchini P.et al. Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII. Br J Haematol. 86:1994;610-618.
40. Dickinson C.D., Kelly C.R., Ruf W. Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa. Proc Natl Acad Sci USA. 93:1996;14379-14384.
41. Higashi S., Matsumoto N., Iwanaga S. Conformation of factor VIIa stabilized by a labile disulfide bond (Cys-310-Cys-329) in the protease domain is essential for interaction with tissue factor. J Biol Chem. 272:1997;25724-25730.
42. Bode W., Fehlhammer H., Huber R. Crystal structure of bovine trypsinogen at 1.8 Å resolution. I. Data collection, application of Patterson search techniques and preliminary structural interpretation. J Mol Biol. 106:1976;325-335.
43. Bode W., Schwager P., Huber R. The transition of bovine trypsinogen to a trypsin-like state upon strong ligand binding. The refined crystal structures of the bovine trypsinogen-pancreatic trypsin inhibitor complex and its ternary complex with Ile-Val at 1.9 Å resolution. J Mol Biol. 118:1978;99-112.
44. Huber R., Bode W. Structural basis of the activation and action of trypsin. Acc Chem Res. 11:1978;114-122.
45. Waxman E., Laws W.R., Laue T.M., Nemerson Y., Ross J.B. Human factor VIIa and its complex with soluble tissue factor: evaluation of asymmetry and conformational dynamics by ultracentrifugation and fluorescence anisotropy decay methods. Biochemistry. 32:1993;3005-3012.
46. McCallum C.D., Hapak R.C., Neuenschwander P.F., Morrissey J.H., Johnson A.E. The location of the active site of blood coagulation factor VIIa above the membrane surface and its reorientation upon association with tissue factor. A fluorescence energy transfer study. J Biol Chem. 271:1996;28168-28175.
47. Ruf W., Miles D.J., Rehemtulla A., Edgington T.S. Cofactor residues lysine 165 and 166 are critical for protein substrate recognition by the tissue factor-factor VIIa protease complex. J Biol Chem. 267:1992;6375-6381.
48. 156. J Biol Chem. 272:1997;28-31.
49. Renatus M., Engh R.A., Stubbs M.T.et al. Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single-chain human tPA. EMBO J. 16:1997;4797-4805.
50. Dickinson C.D., Ruf W. Active site modification of factor VIIa affects interactions of the protease domain with tissue factor. J Biol Chem. 272:1997;19875-19879.
51. Rao L.V., Nordfang O., Hoang A.D., Pendurthi U.R. Mechanism of antithrombin III inhibition of factor VIIa/tissue factor activity on cell surfaces. Comparison with tissue factor pathway inhibitor/factor Xa-induced inhibition of factor VIIa/tissue factor activity. Blood. 85:1995;121-129.
52. 1-antichymotrypsin as seen by enhanced sensitivity to proteolysis. Biochemistry. 35:1996;10608-10615.
53. Kaslik G., Kardos J., Szabo E.et al. Effects of serpin binding on the target proteinase: global stabilization, localized increased structural flexibility, and conserved hydrogen bonding at the active site. Biochemistry. 36:1997;5455-5464.
54. Lee G.F., Lazarus R.A., Kelley R.F. Potent bifunctional anticoagulants: Kunitz domain-tissue factor fusion proteins. Biochemistry. 36:1997;5607-5611.
55. Ragni M., Golino P., Cirillo P.et al. Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis. Cardiologia. 41:1996;51-58.